PCYN.US Procyon Corporation
- Market cap
- USD 1.47M
- P/E
- -
- P/B
- 0.69x
- ROE
- 1.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2025.
Is PCYN.US undervalued?
Graham numberThe Graham number of Procyon Corporation cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Procyon Corporation fundamental analysis
No fundamental analysis for Procyon Corporation yet.
Procyon Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Procyon Corporation
Procyon Corporation, together with its subsidiaries, engages in manufacturing and marketing of wound and skin care products in the United States. The company offers skin and wound care products made with antimicrobial agent under the AMERIGEL hydrogel wound dressing, AMERIGEL post-op surgical kit, AMERIGEL saline wound wash, AMERIGEL care lotion, and AMERIGEL barrier lotion names, as well as EXTREMIT-EASE name. It also provides HELIX3-CP Collagen Powder and HELIX3-CM Collage…
Full company profileProcyon Corporation financial statements
Procyon Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 3.45M | 4.01M | 4.02M | 4.19M | 4.33M | 4.72M | 4.84M | 4.69M | 4.98M | 6.67M |
| Gross Profit | 2.42M | 2.75M | 2.94M | 3.05M | 3.20M | 3.39M | 3.49M | 3.57M | 3.89M | 2.13M |
| Operating Income | -104K | 30.0K | 127K | 97.1K | 153K | 227K | -237K | -97.4K | -232K | -447K |
| EBITDA | 232K | 77.5K | 175K | 152K | 214K | 900K | -22.8K | 166K | 99.5K | 278K |
| Net Income | 110K | 12.4K | -256K | 27.2K | 112K | 694K | -210K | -50.2K | -341K | 33.9K |
| EPS | 0.01 | 0.00 | -0.03 | 0.00 | 0.01 | 0.08 | -0.03 | -0.01 | -0.04 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 3.12M | 2.73M | 2.36M | 2.43M | 2.82M | 4.24M | 3.80M | 3.56M | 3.20M | 3.45M |
| Total Liabilities | 849K | 442K | 326K | 376K | 658K | 1.29M | 1.13M | 946K | 917K | 1.12M |
| Shareholders' Equity | 2.27M | 2.29M | 2.03M | 2.06M | 2.16M | 2.95M | 2.67M | 2.62M | 2.29M | 2.33M |
| Cash & Short-term Investments | 211K | 275K | 424K | 444K | 821K | 1.51M | 1.04M | 1.01M | 909K | 413K |
| Total Debt | 135K | 5.90K | 2.11K | - | 201K | 808K | 857K | 493K | 320K | 139K |
| Cash Flow | ||||||||||
| Operating Cash Flow | 18.7K | 200K | 86.5K | 50.8K | 199K | 280K | -229K | 145K | -61.3K | -441K |
| Capital Expenditure | 73.3K | 35.9K | 46.7K | 28.8K | 23.0K | 65.2K | 82.6K | 180K | 63.9K | 54.5K |
| Free Cash Flow | -54.6K | 164K | 39.8K | 22.1K | 176K | 214K | -312K | -34.7K | -125K | -495K |
| Ratios | ||||||||||
| ROE | 4.8% | 0.5% | -12.6% | 1.3% | 5.2% | 23.5% | -7.9% | -1.9% | -14.9% | 1.5% |
| ROA | 3.5% | 0.5% | -10.8% | 1.1% | 4.0% | 16.4% | -5.5% | -1.4% | -10.6% | 1.0% |
| Net Profit Margin | 3.2% | 0.3% | -6.4% | 0.6% | 2.6% | 14.7% | -4.3% | -1.1% | -6.8% | 0.5% |
| Debt to Equity | 0.06x | 0.00x | 0.00x | - | 0.09x | 0.27x | 0.32x | 0.19x | 0.14x | 0.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Procyon Corporation dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | USD 17.7K | 0.00 | 65.1% |
| 2018 | - | - | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Procyon Corporation
- Insiders 64.47%
- Institutions 0.00%
- Public & others 35.53%
- Shares outstanding 8.14M
- Free float 4.29M
Procyon Corporation company profile
- Company name
- Procyon Corporation
- Ticker
- PCYN.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 19
- Fiscal year end
- June
- Address
- 164 Douglas Rd, Oldsmar, FL, United States, 34677
- Phone
- 727 447 2998
- Website
- procyoncorp.com
About Procyon Corporation
Procyon Corporation, together with its subsidiaries, engages in manufacturing and marketing of wound and skin care products in the United States. The company offers skin and wound care products made with antimicrobial agent under the AMERIGEL hydrogel wound dressing, AMERIGEL post-op surgical kit, AMERIGEL saline wound wash, AMERIGEL care lotion, and AMERIGEL barrier lotion names, as well as EXTREMIT-EASE name. It also provides HELIX3-CP Collagen Powder and HELIX3-CM Collagen Matrix; AMERX wound care kits, AMERX calcium alginate dressings, AMERX foam dressings, AMERX bordered foam dressings, AMERX bordered gauze dressings, AMERX hydrocolloid dressings, and AMERX thin hydrocolloid dressings; and Oakin, which provides healing in wound and problematic skin conditions. The company serves physicians, healthcare providers, hospitals, clinics, institutions, and schools. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.
Procyon Corporation management
3- Mr. Justice W. AndersonCEO, President & Director · born 1977
- Mr. James B. AndersonCFO & Director · born 1970
- Mr. George Otis BorakVice President of Sales - Amerx Health Care Corp. · born 1961